沿海家園(01124.HK)完成向雞西市交出土地 補償金額已全額抵銷回購金額
格隆匯11月15日丨沿海家園(01124.HK)公吿,於2021年8月9日,恆祥開發及沿海中國(各自為公司附屬公司)與雞西市人民政府及雞西雞冠(各自為獨立第三方)訂立協議,據此恆祥開發須向雞西市人民政府交出土地及雞西市人民政府就土地應付的補償金額人民幣2.24億元應全額抵銷回購協議項下恆祥開發及沿海中國應付予雞西雞冠的回購金額。完成交出土地已於2021年8月18日作實及補償金額已全額抵銷回購金額。
鑑於集團目前的財務狀況,經計及土地開發長期延遲且進度緩慢及雞西市物業市場情況不斷惡化,董事認為交出土地以將資源集中於將為集團帶來較高預期回報率的其他物業發展項目符合集團的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.